Add
BJCT.OB to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| BJCT.OB > SEC Filings for BJCT.OB > Form 8-K on 8-Apr-2009 | All Recent SEC Filings |
8-Apr-2009
Entry into a Material Definitive Agreement, Financial Statements
On April 6, 2009, Bioject Medical Technologies Inc. ("Bioject") entered into a Convertible Subordinated Promissory Note Extension Agreement (each, an "Extension") with each of Life Sciences Opportunities Fund II (Institutional), L.P. and Life Sciences Opportunities Fund II, L.P. (collectively, the "LOF Funds") relating to those two Convertible Subordinated Promissory Notes, dated as of December 5, 2007, issued by Bioject to the LOF Funds in the aggregate principal amount of $600,000 (the "Notes"). The Extensions extend the maturity date of the Notes from May 15, 2009 to July 15, 2009.
(d) Exhibits
The following exhibits are filed herewith and this list is intended to constitute the exhibit index:
10.1 Convertible Subordinated Promissory Note Extension Agreement, dated
April 6, 2009, between Bioject Medical Technologies, Inc. and Life
Sciences Opportunities Fund II (Institutional), L.P.
10.2 Convertible Subordinated Promissory Note Extension Agreement, dated April
6, 2009, between Bioject Medical Technologies, Inc. and Life Sciences
Opportunities Fund II, L.P.
|
|
|